06 Jun Pioneering antibody therapies target the world’s most devastating diseases
Roger Nitsch, CEO, Neurimmune, reveals how the search for biotech solutions to issues like Alzheimer’s and coronavirus is accelerating...
interview
05 Jun Biotech firm thinks it has the most active antiviral targeting COVID-19 in development
Patrick Amstutz, PhD, CEO and Co-Founder, Molecular Partners, outlines the company’s pioneering new modality for custom-built medicines You have been CEO of Molecular Partners since November 2016 and have been an important player in the Swiss biotech scene for a number of years. How would evaluate the evolution of the Swiss biotech landscape over the past...
03 Jun A small university with an innovative impact on the big issues
Kilian Stoffel, Rector, University of Neuchâtel, introduces an institution focused on relevant education and research that answers the world’s burning questions ...
02 Jun A Swiss university with a global role in the fight against COVID-19
Prof. Dr. Dr. h. c. Andrea Schenker-Wicki, President, University of Basel, describes the digitalization of education and research that is changing society ...
01 Jun The cantonal university with an international approach
Prof. Dr. Astrid Epiney, President, University of Fribourg, an institution attracting students, educators, researchers and partners from around the world The University of Fribourg is a major innovation driver in the western region of Switzerland, offering a wide range of courses through its five faculties. It is Switzerland’s only bilingual university and has about 10,000 students,...
01 Jun The stunningly beautiful and green tourist haven that fosters entrepreneurship
Dr. Christian Rathgeb, President, Canton of Graubünden, sees the state’s successful local management of coronavirus as an opportunity to push a sustainable agenda Could you provide our readers with a general overview of the Canton of Graubünden? Graubünden is the largest of the 26 cantons—states—in Switzerland and it has around 200,000 inhabitants. It is the only canton...
01 Jun Supply chain innovator reduces risk and complexity for high-value pharmaceuticals
Richard Ettl, CEO and Co-Founder, SkyCell, explains why the “Rolex of containers” has attracted $62 million in financing during the COVID-19 crisis...